Using SGLT2-inhibitors to treat cardiac patients with diabetes

At our 2018 symposium, "Management of Type 2 Diabetes in Patients with CVD: Focus on Heart Failure," nephrologist and scientist Dr. David Cherney explores the use of SGLT2-inhibitors in cardiovascular and renal protection.

[@RM-hq7wn]

Very nice 👍

[@RoshanLovesall]

Beautiful explaination. Continue the good work

[@bishopecart]

Awesome study as it relates to HFrEF

[@mattiaslarsson4085]

Great!

[@ahmedahm1]

2:42 Good explanation ! So can patients with prediabetes and microalbuminuria take SGLT2i ?

[@adrienmonk2469]

Im sorru sir , but the is not a cotransporter Na /K /2Cl in the distal tubel lumen .
you heve to corrcte that .

[@lexus0077]

SGLT 2 ??? ,What is this ?

[@oswaldfernandes8266]

Statistical analysis of covid deaths in diabetics on sglt2 inhibitors will provide the answer

[@oswaldfernandes8266]

The drug is a killer in diabetic covid patients. This fact outweighs the benefits of the drug in view of the pandemic as I have lost my brother Simon because of sglt2 inhibitors

[@amosjuliantampubolon2413]

Covid patient can consume it?

[@prettyyoungthingpyt5015]

This drug dehydrated like hell. You have to be extremely careful with this damn drug. I think I'll stick to insulin.